Literature DB >> 8442409

Neuronal damage in the cerebral cortex of AIDS brains: a morphometric study.

S Weis1, H Haug, H Budka.   

Abstract

Using stereological methods, two cerebral cortical areas from AIDS brains were investigated. Neuronal density, profile area of neurons, and perikaryon volume fraction were measured and compared to age-matched control brains. In the fronto-orbital cortex (area 11) of AIDS brains, a significant loss of neurons was seen. The perikaryon volume fraction was likewise decreased. The size of neurons did not differ between control and AIDS brains. In patients with clinical signs of progressive dementia and in brains with human immunodeficiency virus (HIV)-specific neuropathology (HIV-leukoencephalopathy and/or HIV-encephalitis) as compared to patients lacking these features, a small decrease in neuronal density was noted but this difference did not reach the level of statistical significance (P = 0.16). In the superior parietal lobule (area 7) of AIDS brains, no loss of nerve cells was noted. AIDS patients with progressive dementia and brains with HIV-specific neuropathology showed no difference in neuronal densities as compared to those without such features. We conclude that the fronto-orbital cortex, in contrast to the parietal cortex, is mainly damaged in AIDS brains. Neuronal loss was not significantly correlated with development of dementing symptoms and of HIV-specific neuropathology.

Entities:  

Mesh:

Year:  1993        PMID: 8442409     DOI: 10.1007/bf00227766

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  19 in total

Review 1.  Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force.

Authors: 
Journal:  Neurology       Date:  1991-06       Impact factor: 9.910

Review 2.  HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology.

Authors:  H Budka; C A Wiley; P Kleihues; J Artigas; A K Asbury; E S Cho; D R Cornblath; M C Dal Canto; U DeGirolami; D Dickson
Journal:  Brain Pathol       Date:  1991-04       Impact factor: 6.508

Review 3.  HIV-related neurotoxicity.

Authors:  S A Lipton
Journal:  Brain Pathol       Date:  1991-04       Impact factor: 6.508

4.  History of neuromorphometry.

Authors:  H Haug
Journal:  J Neurosci Methods       Date:  1986-10       Impact factor: 2.390

5.  Neuronal loss in the frontal cortex in HIV infection.

Authors:  I P Everall; P J Luthert; P L Lantos
Journal:  Lancet       Date:  1991-05-11       Impact factor: 79.321

6.  The age-dependent variation of the embedding-shrinkage of neurohistological sections.

Authors:  N L Sass
Journal:  Mikroskopie       Date:  1982-10

7.  Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.

Authors:  D E Brenneman; G L Westbrook; S P Fitzgerald; D L Ennist; K L Elkins; M R Ruff; C B Pert
Journal:  Nature       Date:  1988-10-13       Impact factor: 49.962

8.  Cytomegalovirus (CMV) disease of the brain in AIDS and connatal infection: a comparative study by histology, immunocytochemistry and in situ DNA hybridization.

Authors:  M Schmidbauer; H Budka; W Ulrich; P Ambros
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

9.  Human immunodeficiency virus (HIV) envelope and core proteins in CNS tissues of patients with the acquired immune deficiency syndrome (AIDS).

Authors:  H Budka
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 10.  The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex.

Authors:  R W Price; B Brew; J Sidtis; M Rosenblum; A C Scheck; P Cleary
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

View more
  21 in total

1.  ER-β mediates 17β-estradiol attenuation of HIV-1 Tat-induced apoptotic signaling.

Authors:  Sheila M Adams; Marina V Aksenova; Michael Y Aksenov; Charles F Mactutus; Rosemarie M Booze
Journal:  Synapse       Date:  2010-11       Impact factor: 2.562

2.  Tensor-based Multi-view Feature Selection with Applications to Brain Diseases.

Authors:  Bokai Cao; Lifang He; Xiangnan Kong; Philip S Yu; Zhifeng Hao; Ann B Ragin
Journal:  Proc IEEE Int Conf Data Min       Date:  2014-12

Review 3.  In vivo modeling of HIV-1 mediated neurodegeneration.

Authors:  E Masliah
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

4.  Severe subcortical degeneration in macaques infected with neurovirulent simian immunodeficiency virus.

Authors:  J K Marcario; K F Manaye; K S SantaCruz; P R Mouton; N E J Berman; P D Cheney
Journal:  J Neurovirol       Date:  2004-12       Impact factor: 2.643

5.  Brain atrophy in HIV infection is more strongly associated with CDC clinical stage than with cognitive impairment.

Authors:  V Di Sclafani; R D Mackay; D J Meyerhoff; D Norman; M W Weiner; G Fein
Journal:  J Int Neuropsychol Soc       Date:  1997-05       Impact factor: 2.892

6.  Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia.

Authors:  I P Everall; J D Glass; J McArthur; E Spargo; P Lantos
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  Neuronal expression of human immunodeficiency virus type 1 env proteins in transgenic mice: distribution in the central nervous system and pathological alterations.

Authors:  F Berrada; D Ma; J Michaud; G Doucet; L Giroux; A Kessous-Elbaz
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 8.  Neuronal injury in simian immunodeficiency virus and other animal models of neuroAIDS.

Authors:  Leslie Crews; Margaret R Lentz; R Gilberto Gonzalez; Howard S Fox; Eliezer Masliah
Journal:  J Neurovirol       Date:  2008-08       Impact factor: 2.643

Review 9.  Interactions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation.

Authors:  J L Cadet; I N Krasnova
Journal:  Neurotox Res       Date:  2007-10       Impact factor: 3.911

Review 10.  Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disorders.

Authors:  Jerel Fields; Wilmar Dumaop; T D Langford; Edward Rockenstein; E Masliah
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-08       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.